http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0877612-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5deddb47ccaab1d4da2aacc344dd8717
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1993-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d1c61123ba1225b11f4993d96aa16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65827c8586ea5b34134c0c1a3703077f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f73f7c34bb0be2783ddcfc7625a68c
publicationDate 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0877612-A1
titleOfInvention Use of piperazine derivatives for the treatment of cognitive disorders
abstract PCT No. PCT/GB93/02197 Sec. 371 Date May 3, 1995 Sec. 102(e) Date May 3, 1995 PCT Filed Oct. 25, 1993 PCT Pub. No. WO94/09780 PCT Pub. Date May 11, 1994Piperazine derivatives of formula (I) are useful in the treatment of cognitive disorders. In formula (I), X is a group of (IIa): -(CH2)nCR2R3CONR4R5 or (IIIb): -A-NR6COR7 where n, A, R, R1, R2, R3, R4, R5, R6 and R7 have specified meanings. <IMAGE> (I)
priorityDate 1992-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233609486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67659298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234024893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234162861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226462650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228358049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57271757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9803032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900

Total number of triples: 41.